Comparative study between Fenton and intergrowth 21 charts in a sample of Lebanese premature babies.
Fenton
Growth charts
Intergrowth-21
Percentiles
Premature
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
17 02 2020
17 02 2020
Historique:
received:
24
12
2019
accepted:
10
02
2020
entrez:
19
2
2020
pubmed:
19
2
2020
medline:
13
3
2021
Statut:
epublish
Résumé
Different charts are used to assess premature growth. The Fenton chart, based on prenatal growth, has been used in the neonates' intensive care unit (NICU) of the Notre Dame des Secours University Hospital to assess premature newborns' development. Intergrowth21 is a new multidisciplinary, multiethnic growth chart better adapted to premature growth. Our objective was to compare both charts Fenton and Intergrowth21 in order to implement Intergrowth in our unit. We analyzed 318 files of premature babies born who were admitted to the NICU from 2010 till 2017. Anthropometric data (weight, height and head circumference) converted to percentiles was filled on both charts from birth till 1 month of age. The results of the linear regression, taking the weight at birth as the dependent variable, showed that the Fenton scale (R2 = 0.391) would predict the weight at birth better than the Intergrowth 21 scale (R2 = 0.257). The same applies for height and cranial perimeter at birth when taken as dependent variables. When considering the weight and height at 2 weeks, the results showed that the Intergrowth 21 scale would predict those variables better than the Fenton scale, with higher R2 values higher in favor of the Intergrowth 21 scale for both weight (0.384 vs 0.311) and height (0.650 vs 0.585). At 4 weeks, the results showed that the Fenton scale would predict weight (R2 = 0.655 vs 0.631) and height (R2 = 0.710 vs 0.643) better than the Intergrowth 21 scale. The results obtained were adjusted over the newborns' sociodemographic and clinical factors. The results of our study are controversial where the Fenton growth charts are superior to Intergrowth 21 before 2 weeks of age and at 4 weeks, whereas Intergrowth 21 charts showed higher percentiles for weight and height than Fenton charts at 2 two weeks of age. Further studies following a different design, such as a clinical trial or a prospective study, taking multiple ethnicities into account and conducted in multiple centers should be considered to enroll a more representative sample of Lebanese children and be able to extrapolate our results to the national level.
Sections du résumé
BACKGROUND
Different charts are used to assess premature growth. The Fenton chart, based on prenatal growth, has been used in the neonates' intensive care unit (NICU) of the Notre Dame des Secours University Hospital to assess premature newborns' development. Intergrowth21 is a new multidisciplinary, multiethnic growth chart better adapted to premature growth. Our objective was to compare both charts Fenton and Intergrowth21 in order to implement Intergrowth in our unit.
METHODS
We analyzed 318 files of premature babies born who were admitted to the NICU from 2010 till 2017. Anthropometric data (weight, height and head circumference) converted to percentiles was filled on both charts from birth till 1 month of age.
RESULTS
The results of the linear regression, taking the weight at birth as the dependent variable, showed that the Fenton scale (R2 = 0.391) would predict the weight at birth better than the Intergrowth 21 scale (R2 = 0.257). The same applies for height and cranial perimeter at birth when taken as dependent variables. When considering the weight and height at 2 weeks, the results showed that the Intergrowth 21 scale would predict those variables better than the Fenton scale, with higher R2 values higher in favor of the Intergrowth 21 scale for both weight (0.384 vs 0.311) and height (0.650 vs 0.585). At 4 weeks, the results showed that the Fenton scale would predict weight (R2 = 0.655 vs 0.631) and height (R2 = 0.710 vs 0.643) better than the Intergrowth 21 scale. The results obtained were adjusted over the newborns' sociodemographic and clinical factors.
CONCLUSION
The results of our study are controversial where the Fenton growth charts are superior to Intergrowth 21 before 2 weeks of age and at 4 weeks, whereas Intergrowth 21 charts showed higher percentiles for weight and height than Fenton charts at 2 two weeks of age. Further studies following a different design, such as a clinical trial or a prospective study, taking multiple ethnicities into account and conducted in multiple centers should be considered to enroll a more representative sample of Lebanese children and be able to extrapolate our results to the national level.
Identifiants
pubmed: 32066413
doi: 10.1186/s12887-020-1968-7
pii: 10.1186/s12887-020-1968-7
pmc: PMC7025416
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Références
Am J Obstet Gynecol. 2016 Apr;214(4):509.e1-509.e7
pubmed: 26546850
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
J Matern Fetal Neonatal Med. 2018 Sep;31(17):2252-2257
pubmed: 28587527
Natl Vital Stat Rep. 2018 Nov;67(8):1-50
pubmed: 30707672
J Pediatr. 2018 May;196:77-83
pubmed: 29246464
Pediatrics. 2013 Apr;131(4):e1240-63
pubmed: 23509172
Front Endocrinol (Lausanne). 2019 Feb 07;10:55
pubmed: 30792696
Pediatrics. 2016 Dec;138(6):
pubmed: 27940743
Arch Dis Child Fetal Neonatal Ed. 2004 Sep;89(5):F428-30
pubmed: 15321963
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Vaccine. 2017 Dec 4;35(48 Pt A):6518-6528
pubmed: 29150057
Pediatrics. 2018 Feb;141(2):
pubmed: 29301912
JAMA Pediatr. 2015 Jul;169(7):e151438
pubmed: 26147059
Pediatrics. 2017 Mar;139(3):
pubmed: 28246339